|Bid||9.74 x 0|
|Ask||9.85 x 0|
|Day's Range||9.71 - 9.85|
|52 Week Range||8.49 - 12.95|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.36 (3.75%)|
|1y Target Est||11.21|
Aurora Cannabis to Host Fourth Quarter 2018 Investor Conference Call on September 25, 2018
WKN: A1C4WM), today announced that it has completed its previously announced distribution of Australis shares and warrants (the "Distribution"). In accordance with the terms of the Distribution, eligible Aurora shareholders were paid one unit of Australis for every 34 Aurora shares outstanding as at August 24, 2018 (the "Record Date). Each unit consists of one common share and one share purchase warrant of Australis.
WKN: A1C4WM) today announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia , Alberta , Ontario , Quebec and Nova Scotia , the Company is pleased to advise of arrangements with Yukon , Manitoba , Prince Edward Island and Newfoundland and Labrador . The Aurora and MedReleaf brands are expected to have a strong presence across Canada , positioning the Company well for rapid growth in the upcoming adult use market.
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Companies
Alcanna Inc. (“Alcanna” or the "Company") (CLIQ.TO) announced today a cash dividend of $0.09 per common share (“Common Share”) of the Company for the third quarter of 2018. The dividend will be paid on October 15, 2018, to holders of record of the Common Shares on September 28, 2018. This dividend is an "eligible dividend" for Canadian income tax purposes. The Company has a Dividend Reinvestment Plan (the “DRIP”) which allows eligible shareholders of the Company to direct that their cash dividends be reinvested in additional Common Shares.
WKN: A1C4WM) and Australis Capital Inc. ("Australis") today announced the common shares and warrants (together the "Units") of Australis are expected to commence trading on the Canadian Securities Exchange (the "CSE") under the trading symbol "AUSA" at the opening of trading on September 19, 2018 immediately following the completion of the distribution of Units by Aurora to its shareholders. To date, the medical use of cannabis is legal in 31 states, the District of Columbia and the territories of Guam and Puerto Rico .
WKN: A1C4WM) and Australis Capital Inc. ("Australis") today announced the common shares and warrants (together the "Units") of Australis are expected to commence trading on the Canadian Securities Exchange (the "CSE") under the trading symbol "AUSA" at the opening of trading on September 19, 2018 immediately following the completion of the distribution of Units by Aurora to its shareholders.
WKN: A1C4WM) are pleased to launch a new guide to cannabis legalization for municipal candidates, with a view to raising awareness of the new cannabis laws that will come into effect next month. Local BC government leaders are gathering this week for the annual Union of BC Municipalities (UBCM) convention in Whistler, BC , in advance of this year's municipal elections that are taking place next month.
WKN: A1C4WM) and ICC Labs Inc. (ICC.V) (ICC) announced today that the companies have entered into a definitive arrangement agreement pursuant to which Aurora intends to acquire all of the issued and outstanding common shares of ICC (the ICC Shares) for $1.95 per share (payable in common shares of Aurora (the Aurora Shares) (the Share Consideration), reflecting an aggregate purchase price of approximately $290 million (the Transaction). The Transaction has been unanimously approved by the Board of Directors of each ICC and Aurora.
Aurora Cannabis Receives Production License for Aurora Eau Facility and Oils Production License for MedReleaf's Bradford Facility
WKN: A1C4WM) today reaffirmed its commitment to advocating for the amnesty of cannabis possession offenses through a $50,000 contribution to the Campaign for Cannabis Amnesty. The organization will use the funds to advocate for the expungement of criminal records for personal possession cannabis offences that will no longer be illegal after October 17, 2018 , and to educate Canadians about the injustices that currently exist as a result of the prohibition of cannabis.
Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production at Aurora Vie Facility and launches CanniMed Capsules 3:3
WKN: A1C4WM) is pleased to confirm it, and its wholly-owned subsidiary MedReleaf, have entered into supply agreements with the Ontario Cannabis Stores, a key market in the Company's adult consumer use strategy. When government-run online sales commence on October 17 , Aurora and MedReleaf will supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules.
WKN: A1C4WM) today announced that, in connection with the spin-out of its subsidiary Australis Capital Inc. ("Australis"), Aurora has set Friday August 24, 2018 as the record date for the distribution of Australis units (the "Distribution"). Canadian shareholders as at the record date will be eligible to receive the Distribution. Non-resident shareholders will be entitled to receive a cash payment net of any applicable withholding taxes following a sale of their respective units in the open market by an independent custodian following the Distribution.
WKN: A1C4WM) today announced, in connection with the spin-out of its subsidiary Australis Capital Inc. ("Australis"), Australis has received a receipt for its final prospectus dated August 14, 2018 (the "Final Prospectus"). The Final Prospectus was filed with the securities regulatory authorities in all provinces and territories of Canada and is available under Australis' SEDAR profile at www.sedar.com. Receipt of the Final Prospectus will permit Aurora's Board of Directors (the "Board") to set the Record date of the transaction, which the company expects the Board will announce within the coming days. Additionally, Australis received conditional approval to list its shares and warrants on the Canadian Securities Exchange ("CSE"), as well as completed an oversubscribed private placement for proceeds of $17 million .
Alcanna Inc. (the “Company” or “Alcanna”) (CLIQ.TO) announced that Elise Rees, FCPA, FCA, ICD.D has joined its Board of Directors. “Ms. Rees is a Vancouver resident with a long professional background advising clients on finances and tax, specializing in mergers and acquisitions. Elise brings over 36 years of experience advising clients on finances and tax, specializing in mergers and acquisitions for 14 of those years.
WKN: A1C4WM) and Alcanna Inc. ("Alcanna") (CLIQ.TO) applaud the Ontario Government on its new plans for the responsible sale of recreational cannabis products through government-operated online sales, and the private sector. Aurora and Alcanna have entered into a license agreement which – as soon as regulations permit – will allow Alcanna to open retail cannabis stores under the brand name "Aurora".
WKN: A1C4WM) today announced that its acquisition of Anandia Laboratories Inc. ("Anandia") is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act ( British Columbia ), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the "Transaction"). Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.
While small-cap stocks, such as Alcanna Inc (TSE:CLIQ) with its market cap of CA$370.96m, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
WKN: A1C4WM) is pleased to provide the following update on its international operations. The Company has successfully shipped cultivars from its Mountain facility to Denmark to commence populating the Phase I Aurora Nordic facility, a 100,000 square foot, retrofitted hybrid greenhouse, which will be ramping up to full production capacity of 8,000 kg per year of medical cannabis over the coming months. Aurora Nordic is a 51%-Aurora owned subsidiary owned in partnership with Alfred Pederson & Son.
Alcanna Inc. (the “Company” or “Alcanna”) (CLIQ.TO) today reported its results for the three and six months ended June 30, 2018. “Alcanna is a very different company than Liquor Stores N.A. was. “We are excited by the opportunities in front of us to capitalize on our profitable Wine and Beyond large format liquor stores, expand our successful new Deep Discount Liquor brand, and of course enter the cannabis business on October 17th in a major way.